| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.31 | 0.05 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.32 | 0.06 |